Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis

American Journal of Kidney Diseases

Volumn 60, Issue 3, 2012, Pages 473-486

  Shen, Jenny I ^a   Winkelmayer, Wolfgang C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anticoagulation; bleeding; complications; hemodialysis; Heparin

Indexed keywords

ACETYLSALICYLIC ACID; ARGATROBAN; CITRIC ACID; DALTEPARIN; DANAPAROID; DESULFATOHIRUDIN; DRUG ANTIBODY; ENOXAPARIN; ERYTHROPOIETIN; FONDAPARINUX; HEMOGLOBIN; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN; TINZAPARIN;

ABDOMINAL PAIN; ADULT; ANGIONEUROTIC EDEMA; ANTICOAGULANT THERAPY; ARTERIOVENOUS FISTULA; ARTICLE; ARTIFICIAL KIDNEY; BLEEDING; BLOOD PRESSURE; BODY TEMPERATURE; BRAIN HEMORRHAGE; CASE REPORT; CATHETER INFECTION; CLINICAL FEATURE; CLINICAL PROTOCOL; COLON PERFORATION; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIAPHORESIS; DRUG COST; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MANUFACTURE; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; DYSPNEA; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE SYSTEM; HEMICOLECTOMY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERKALEMIA; HYPERTRIGLYCERIDEMIA; HYPOALDOSTERONISM; HYPOTENSION; HYPOXIA; IMMUNOASSAY; INTESTINE ISCHEMIA; KIDNEY FAILURE; LABORATORY TEST; LEUKOCYTE COUNT; LOADING DRUG DOSE; LONG TERM CARE; LOW DRUG DOSE; LUNG EMBOLISM; MAINTENANCE THERAPY; MALE; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; NAUSEA; OSTEOPOROSIS; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PERITONEAL DIALYSIS; PHYSICAL EXAMINATION; PULSE RATE; RETROPERITONEAL HEMORRHAGE; RISK ASSESSMENT; SIDE EFFECT; TACHYCARDIA; TACHYPNEA; THROMBOCYTE COUNT; THROMBOEMBOLISM; URTICARIA; VOMITING;

ANTICOAGULANTS; BLOOD COAGULATION; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HEMORRHAGE; HEPARIN; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LONG-TERM CARE; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PATIENT SAFETY; RENAL DIALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84865687658     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.03.017     Document Type: Article

References (127)

1. US Renal Data System USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States Am J Kidney Dis 57 1(suppl 1) 2011 e1 e526
2. J.S. Cameron Practical haemodialysis began with cellophane and heparin: the crucial role of William Thalhimer (1884-1961) Nephrol Dial Transplant 15 7 2000 1086 1091
3. S.K. Fellner, M.L. Purkerson Gordon Murray: heparin, hemodialysis and hubris Am J Nephrol 22 2-3 2002 271 277
4. P. Brunet, N. Simon, A. Opris Pharmacodynamics of unfractionated heparin during and after a hemodialysis session Am J Kidney Dis 51 5 2008 789 795
5. R.E. Cronin, R.F. Reilly Unfractionated heparin for hemodialysis: still the best option Semin Dial 23 5 2010 510 515
6. Y. Schmitt, H. Schneider Low-molecular-weight heparin (LMWH): influence on blood lipids in patients on chronic haemodialysis Nephrol Dial Transplant 8 5 1993 438 442
7. J. Ethier, J.L. Bragg-Gresham, L. Piera Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 50 4 2007 602 611
8. R. Saran, D.M. Dykstra, R.A. Wolfe, B. Gillespie, P.J. Held, E.W. Young Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 40 6 2002 1255 1263
9. K.E. Chan, J.M. Lazarus, R. Thadhani, R.M. Hakim Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients J Am Soc Nephrol 20 4 2009 872 881
10. R.M. Holden, G.J. Harman, M. Wang, D. Holland, A.G. Day Major bleeding in hemodialysis patients Clin J Am Soc Nephrol 3 1 2008 105 110
11. H. Reinecke, E. Brand, R. Mesters Dilemmas in the management of atrial fibrillation in chronic kidney disease J Am Soc Nephrol 20 4 2009 705 711
12. A.S. Go, M.C. Fang, N. Udaltsova Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study Circulation 119 10 2009 1363 1369
13. P.J. Phelan, P. O'Kelly, J. Holian Warfarin use in hemodialysis patients: what is the risk? Clin Nephrol 75 3 2011 204 211
14. V. Wizemann, L. Tong, S. Satayathum Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy Kidney Int 77 12 2010 1098 1106
15. W.C. Winkelmayer, J. Liu, S. Setoguchi, N.K. Choudhry Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation Clin J Am Soc Nephrol 6 11 2011 2662 2668
16. P.G. Blake, J.T. Daugirdas, T.S. Ing Handbook of Dialysis 4th ed. 2007 Lippincott Williams & Wilkins Philadelphia, PA
17. J.I. Weitz Antiplatelet, anticoagulant, and fibrinolytic drugs D.L. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J.L. Jameson, J. Loscalzo, Harrison's Principles of Internal Medicine 18th ed. 2012 McGraw-Hill New York http://www.accessmedicine.com/content.aspx?aID=9101027 Accessed April 16, 2012
18. J. Chanard, S. Lavaud, H. Maheut, I. Kazes, F. Vitry, P. Rieu The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane Nephrol Dial Transplant 23 6 2008 2003 2009
19. K.B. Lee, B. Kim, Y.H. Lee Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding Nephron Clin Pract 97 1 2004 c5 c10
20. B. Gunnarsson, H. Asaba, S. Dawidson, S. Wilhelmsson, J. Bergstrom The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers Clin Nephrol 15 3 1981 135 142
21. J. Norton, R. Spiezio, L. LaManna, B. DeLorme Varying heparin requirements in hemodialysis patients receiving erythropoietin ANNA J 19 4 1992 367 372 408; discussion 409
22. N. Veys, R. Vanholder, K. De Cuyper, S. Ringoir Influence of erythropoietin on dialyzer reuse, heparin need, and urea kinetics in maintenance hemodialysis patients Am J Kidney Dis 23 1 1994 52 59
23. B.S. Spinowitz, J. Arslanian, C. Charytan, R.A. Golden, J. Rascoff, M. Galler Impact of epoetin beta on dialyzer clearance and heparin requirements Am J Kidney Dis 18 6 1991 668 673
24. R.S. Aquino, M.S. Pereira, B.C. Vairo Heparins from porcine and bovine intestinal mucosa: are they similar drugs? Thromb Haemost 103 5 2010 1005 1015
25. L. Krauskopf FDA issues plan to avoid heparin contamination Reuters.com http://www.reuters.com/article/2012/02/10/us-fda-heparin-idUSTRE8190RB20120210 2012 Accessed February 13, 2012
26. D.B. Blossom, A.J. Kallen, P.R. Patel Outbreak of adverse reactions associated with contaminated heparin N Engl J Med 359 25 2008 2674 2684
27. J.C. Dooren Suppliers linked to impure heparin Wall Street J 2012 http://online.wsj.com/article/SB10001424052970203960804577239624228625522.html Accessed March 23, 2012
28. A. Davenport Optimization of heparin anticoagulation for hemodialysis Hemodial Int 15 suppl 1 2011 S43 S48
29. R. Ouseph, R.A. Ward Anticoagulation for intermittent hemodialysis Semin Dial 13 3 2000 181 187
30. G. Mingardi, N. Perico, F. Pusineri Heparin for hemodialysis: practical guidelines for administration and monitoring Int J Artif Organs 7 5 1984 269 274
31. S. Wilhelmsson, L.E. Lins Heparin elimination and hemostasis in hemodialysis Clin Nephrol 22 6 1984 303 306
32. R.A. Ward, P.C. Farrell Precise anticoagulation for routine hemodialysis using nomograms Trans Am Soc Artif Intern Organs 24 1978 439 442
33. C.L. Low, G. Bailie, S. Morgan, G. Eisele Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients Clin Nephrol 45 2 1996 120 124
34. R.J. Kandrotas, P. Gal, J.B. Douglas, J. Deterding Pharmacokinetics and pharmacodynamics of heparin during hemodialysis: interpatient and intrapatient variability Pharmacotherapy 10 5 1990 349 355
35. T.C. Jannett, M.G. Wise, N.H. Shanklin, P.W. Sanders Adaptive control of anticoagulation during hemodialysis Kidney Int 45 3 1994 912 915
36. R. Ouseph, M.E. Brier, R.A. Ward Improved dialyzer reuse after use of a population pharmacodynamic model to determine heparin doses Am J Kidney Dis 35 1 2000 89 94
37. S.S. Ehrmeyer, R.H. Laessig Regulatory compliance for point-of-care testing: 2009 United States perspective Clin Lab Med 29 3 2009 463 478
38. European Best Practice Guidelines Working Group Section V Chronic intermittent haemodialysis and prevention of clotting in the extracorporal system Nephrol Dial Transplant 17 suppl 7 2002 63 71
39. L.A. Gordon, H.A. Perkins, V. Richards Studies in regional heparinization I. The use of simultaneous neutralization with protamine; preliminary studies N Engl J Med 255 22 1956 1025 1029
40. C.L. Hampers, M.D. Balufox, J.P. Merrill Anticoagulation rebound after hemodialysis N Engl J Med 275 14 1966 776 778
41. M.D. Blaufox, C.L. Hampers, J.P. Merrill Rebound anticoagulation occurring after regional heparinization for hemodialysis Trans Am Soc Artif Intern Organs 12 1966 207 209
42. S. Lavaud, B. Paris, H. Maheut Assessment of the heparin-binding AN69 ST hemodialysis membrane: II Clinical studies without heparin administration ASAIO J 51 4 2005 348 351
43. M.J. Wright, G. Woodrow, S. Umpleby, S. Hull, A.M. Brownjohn, J.H. Turney Low thrombogenicity of polyethylene glycol-grafted cellulose membranes does not influence heparin requirements in hemodialysis Am J Kidney Dis 34 1 1999 36 42
44. P. Evenepoel Heparin-coated hemodialyzers - the holy grail for patients at risk of bleeding? Nephron Clin Pract 97 1 2004 c1 c2
45. R.D. Swartz, F.K. Port Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin Kidney Int 16 4 1979 513 518
46. R.D. Swartz Hemorrhage during high-risk hemodialysis using controlled heparinization Nephron 28 2 1981 65 69
47. H. Wasse, D.L. Gillen, A.M. Ball Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients Kidney Int 64 4 2003 1455 1461
48. A. Chachati, J.P. Godon Effect of haemodialysis on upper gastrointestinal tract pathology in patients with chronic renal failure Nephrol Dial Transplant 1 4 1987 233 237
49. J.Y. Yang, T.C. Lee, M.E. Montez-Rath et al. Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients J Am Soc Nephrol 23 3 2012 495 506
50. C.D. Baroni The pathobiography and death of Wolfgang Amadeus Mozart: from legend to reality Hum Pathol 28 5 1997 519 521
51. S.L. Seliger, D.L. Gillen, W.T. Longstreth Jr, B. Kestenbaum, C.O. Stehman-Breen Elevated risk of stroke among patients with end-stage renal disease Kidney Int 64 2 2003 603 609
52. M. Kawamura, S. Fijimoto, S. Hisanaga, Y. Yamamoto, T. Eto Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis Am J Kidney Dis 31 6 1998 991 996
53. K. Iseki, K. Kinjo, Y. Kimura, A. Osawa, K. Fukiyama Evidence for high risk of cerebral hemorrhage in chronic dialysis patients Kidney Int 44 5 1993 1086 1090
54. H.K. Bhasin, C.L. Dana Spontaneous retroperitoneal hemorrhage in chronically hemodialyzed patients Nephron 22 4-6 1978 322 327
55. S. Vanichayakornkul, R.F. Cioffi, E. Harper, J.M. O'Connell, R.J. Shalhoub Spontaneous retroperitoneal hematoma A complication of hemodialysis JAMA 230 8 1974 1164 1165
56. N.G. De Santo, G. Capodicasa, N. Perna, C. De Pascale, C. Giordano Haematoma of rectus abdominis associated with dialysis Br Med J 3 5821 1972 281 282
57. J. Milutinovich, W.C. Follette, B.H. Scribner Spontaneous retroperitoneal bleeding in patients on chronic hemodialysis Ann Intern Med 86 2 1977 189 192
58. H. Hayashi, Y. Kurata, Y. Imanaga, K. Goya, K. Oshima Vitrectomy for diabetic retinopathy in patients undergoing hemodialysis for associated end-stage renal failure Retina 18 2 1998 156 159
59. M.M. Slusher, R.W. Hamilton Spontaneous hyphema during hemodialysis [letter] N Engl J Med 293 11 1975 561
60. M.A. Galen, S.M. Steinberg, E.G. Lowrie, J.M. Lazarus, C.L. Hampers, J.P. Merrill Hemorrhagic pleural effusion in patients undergoing chronic hemodialysis Ann Intern Med 82 3 1975 359 361
61. A.C. Alfrey, J.E. Goss, D.A. Ogden, J.H. Vogel, J.H. Holmes Uremic hemopericardium Am J Med 45 3 1968 391 400
62. A. Davenport Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis Am J Kidney Dis 54 2 2009 361 374
63. B.H. Chong Heparin-induced thrombocytopenia Blood Rev 2 2 1988 108 114
64. A. Davenport Heparin-induced thrombocytopenia during renal replacement therapy Hemodial Int 8 3 2004 295 303
65. W.C. Aird, E.J. Mark Case records of the Massachusetts General Hospital Weekly clinicopathological exercises. Case 15-200. A 53-year-old man with a myocardial infarct and thromboses after coronary-artery bypass grafting N Engl J Med. 346 20 2002 1562 1570
66. D.J. King, J.G. Kelton Heparin-associated thrombocytopenia Ann Intern Med 100 4 1984 535 540
67. T.E. Warkentin, A. Greinacher, A. Koster, A.M. Lincoff Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6(suppl) 2008 340S 380S
68. C.A. Hutchison, I. Dasgupta National survey of heparin-induced thrombocytopenia in the haemodialysis population of the UK population Nephrol Dial Transplant 22 6 2007 1680 1684
69. S. Yamamoto, M. Koide, M. Matsuo Heparin-induced thrombocytopenia in hemodialysis patients Am J Kidney Dis 28 1 1996 82 85
70. J.J. Chang, C.R. Parikh When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients Semin Dial 19 4 2006 297 304
71. T. Matsuo, H. Kobayashi, M. Matsuo Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis Pathophysiol Haemost Thromb 35 6 2006 445 450
72. L. Mureebe, R.D. Coats, W.R. Silliman, T.A. Shuster, W.K. Nichols, D. Silver Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients Surgery 136 4 2004 848 853
73. P. Carrozza, L. Gabutti, F. Gilliet, C. Marone Heparin-induced systemic inflammatory response syndrome with progressive skin necrosis in haemodialysis Nephrol Dial Transplant 12 11 1997 2424 2427
74. M. Leblanc, L.F. Roy, L. Legault, L.R. Dufresne, C. Morin, C. Thuot Severe skin necrosis associated with heparin in hemodialysis Nephron 68 1 1994 133 137
75. D. Popov, M.H. Zarrabi, H. Foda, M. Graber Pseudopulmonary embolism: acute respiratory distress in the syndrome of heparin-induced thrombocytopenia Am J Kidney Dis 29 3 1997 449 452
76. A. Davenport Sudden collapse during haemodialysis due to immune-mediated heparin-induced thrombocytopaenia Nephrol Dial Transplant 21 6 2006 1721 1724
77. T.E. Warkentin, N.M. Heddle Laboratory diagnosis of immune heparin-induced thrombocytopenia Curr Hematol Rep 2 2 2003 148 157
78. T.E. Warkentin, A. Greinacher Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3(suppl) 2004 311S 337S
79. L. Pena de la Vega, R.S. Miller, M.M. Benda Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study Mayo Clin Proc 80 8 2005 995 1000
80. H. Nakamoto, Y. Shimada, T. Kanno, K. Wanaka, T. Matsuo, H. Suzuki Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis Hemodial Int 9 suppl 1 2005 S2 S7
81. M. Carrier, M.A. Rodger, D. Fergusson Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex Kidney Int 73 2 2008 213 219
82. V. Krane, M. Berger, J. Lilienthal, K. Winkler, C. Schambeck, C. Wanner Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes Clin J Am Soc Nephrol 5 5 2010 874 881
83. M. Carrier, G.A. Knoll, M.J. Kovacs, J.C. Moore, D. Fergusson, M.A. Rodger The prevalence of antibodies to the platelet factor 4-heparin complex and association with access thrombosis in patients on chronic hemodialysis Thromb Res 120 2 2007 215 220
84. B. Nasstrom, G. Olivecrona, T. Olivecrona, B.G. Stegmayr Lipoprotein lipase during heparin infusion: lower activity in hemodialysis patients Scand J Clin Lab Invest 63 1 2003 45 53
85. B. Nasstrom, B. Stegmayr, G. Olivecrona, T. Olivecrona Lipoprotein lipase in hemodialysis patients: indications that low molecular weight heparin depletes functional stores, despite low plasma levels of the enzyme BMC Nephrol 5 2004 17
86. M.S. Elisaf, N.P. Germanos, H.T. Bairaktari, M.B. Pappas, E.I. Koulouridis, K.C. Siamopoulos Effects of conventional vs. low-molecular-weight heparin on lipid profile in hemodialysis patients Am J Nephrol 17 2 1997 153 157
87. J. Wiemer, K. Winkler, M. Baumstark, W. Marz, J.E. Scherberich Influence of low molecular weight heparin compared to conventional heparin for anticoagulation during haemodialysis on low density lipoprotein subclasses Nephrol Dial Transplant 17 12 2002 2231 2238
88. C. Yang, T. Wu, C. Huang Low molecular weight heparin reduces triglyceride, VLDL and cholesterol/HDL levels in hyperlipidemic diabetic patients on hemodialysis Am J Nephrol 18 5 1998 384 390
89. H.J. Deuber, W. Schulz Reduced lipid concentrations during four years of dialysis with low molecular weight heparin Kidney Int 40 3 1991 496 500
90. F. Kronenberg, P. Konig, K. Lhotta, A. Steinmetz, H. Dieplinger Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients Clin Nephrol 43 6 1995 399 404
91. F. Kronenberg, P. Konig, U. Neyer Influence of various heparin preparations on lipoproteins in hemodialysis patients: a multicentre study Thromb Haemost 74 4 1995 1025 1028
92. C. Hottelart, J.M. Achard, P. Moriniere, F. Zoghbi, J. Dieval, A. Fournier Heparin-induced hyperkalemia in chronic hemodialysis patients: comparison of low molecular weight and unfractionated heparin Artif Organs 22 7 1998 614 617
93. T. Bottio, G. Pittarello, R. Bonato, U. Fagiolo, G. Gerosa Life-threatening anaphylactic shock caused by porcine heparin intravenous infusion during mitral valve repair J Thorac Cardiovasc Surg 126 4 2003 1194 1195
94. A. Harada, K. Tatsuno, T. Kikuchi Use of bovine lung heparin to obviate anaphylactic shock caused by porcine gut heparin Ann Thorac Surg 49 5 1990 826 827
95. S. Schulman, M. Hellgren-Wangdahl Pregnancy, heparin and osteoporosis Thromb Haemost 87 2 2002 180 181
96. D.N. Binici, N. Gunes Risk factors leading to reduced bone mineral density in hemodialysis patients with metabolic syndrome Ren Fail 32 4 2010 469 474
97. K.N. Lai, K. Ho, R.C. Cheung Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis Int J Artif Organs 24 7 2001 447 455
98. T.E. Edes, E.V. Sunderrajan Heparin-induced hyperkalemia Arch Intern Med 145 6 1985 1070 1072
99. C.J. Diskin, T.J. Stokes, L.M. Dansby, L. Radcliff, T.B. Carter Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors Nephron Clin Pract 107 4 2007 c128 c132
100. R.M. Shanks, N.P. Donegan, M.L. Graber Heparin stimulates Staphylococcus aureus biofilm formation Infect Immun 73 8 2005 4596 4606
101. G.R. Hetzel, C. Sucker The heparins: all a nephrologist should know Nephrol Dial Transplant 20 10 2005 2036 2042
102. T.E. Warkentin, M.N. Levine, J. Hirsh Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 20 1995 1330 1335
103. W. Lim, D.J. Cook, M.A. Crowther Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials J Am Soc Nephrol 15 12 2004 3192 3206
104. M.A. Crowther, L.R. Berry, P.T. Monagle, A.K. Chan Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin Br J Haematol 116 1 2002 178 186
105. A. Davenport Review article: low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments Nephrology (Carlton) 14 5 2009 455 461
106. J.J. Borm, R. Krediet, A. Sturk, J.W. ten Cate Heparin versus low molecular weight heparin K 2165 in chronic hemodialysis patients: a randomized cross-over study Haemostasis 16 suppl 2 1986 59 68
107. J. Schrader, W. Stibbe, V.W. Armstrong Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration Kidney Int 33 4 1988 890 896
108. E. Anastassiades, D.A. Lane, H. Ireland, A. Flynn, J.R. Curtis A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin Clin Nephrol 32 6 1989 290 296
109. M.T. Nurmohamed, J. ten Cate, P. Stevens, J.A. Hoek, R.L. Lins, J.W. ten Cate Long-term efficacy and safety of a low molecular weight heparin in chronic hemodialysis patients A comparison with standard heparin ASAIO Trans 37 3 1991 M459 M461
110. K.E. Ryan, D.A. Lane, A. Flynn, J. Shepperd, H.A. Ireland, J.R. Curtis Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis Thromb Haemost 66 3 1991 277 282
111. J. Harenberg, B. Haaf, C.E. Dempfle, G. Stehle, D.L. Heene Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay Nephrol Dial Transplant 10 2 1995 217 222
112. M. Moia, G. Graziani, P.M. Tenconi, I. Martinelli, C. Ponticelli Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patients Ann Ital Med Int 12 2 1997 67 71
113. D. Saltissi, C. Morgan, J. Westhuyzen, H. Healy Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation Nephrol Dial Transplant 14 11 1999 2698 2703
114. S. Stefoni, G. Cianciolo, G. Donati Standard heparin versus low-molecular-weight heparin A medium-term comparison in hemodialysis Nephron 92 3 2002 589 600
115. H. Lord, N. Jean, M. Dumont, J. Kassis, M. Leblanc Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center Am J Nephrol 22 1 2002 58 66
116. J.G. Leu, S.S. Chiang, S.M. Lin, J.K. Pai, W.W. Jiang Low molecular weight heparin in hemodialysis patients with a bleeding tendency Nephron 86 4 2000 499 501
117. M.J. Hursting, P.T. Murray Argatroban anticoagulation in renal dysfunction: a literature analysis Nephron Clin Pract 109 2 2008 c80 c94
118. A. Greinacher, T.E. Warkentin The direct thrombin inhibitor hirudin Thromb Haemost 99 5 2008 819 829
119. V. van Wyk, P.N. Badenhorst, H.G. Luus, H.F. Kotze A comparison between the use of recombinant hirudin and heparin during hemodialysis Kidney Int 48 4 1995 1338 1343
120. H.N. Magnani A review of 122 published outcomes of danaparoid anticoagulation for intermittent haemodialysis Thromb Res 125 4 2010 e171 e176
121. R.M. Kalicki, F. Aregger, L. Alberio, B. Lammle, F.J. Frey, D.E. Uehlinger Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis Thromb Haemost 98 6 2007 1200 1207
122. R. Apsner, H. Buchmayer, D. Gruber, G. Sunder-Plassmann Citrate for long-term hemodialysis: prospective study of 1,009 consecutive high-flux treatments in 59 patients Am J Kidney Dis 45 3 2005 557 564
123. R.J. Caruana, R.M. Raja, J.V. Bush, M.S. Kramer, S.J. Goldstein Heparin free dialysis: comparative data and results in high risk patients Kidney Int 31 6 1987 1351 1355
124. F. Keller, J. Seemann, L. Preuschof, G. Offermann Risk factors of system clotting in heparin-free haemodialysis Nephrol Dial Transplant 5 9 1990 802 807
125. S. Casati, M. Moia, G. Graziani Hemodialysis without anticoagulants: efficiency and hemostatic aspects Clin Nephrol 21 2 1984 102 105
126. L. Preuschof, F. Keller, J. Seemann, G. Offermann Heparin-free hemodialysis with prophylactic change of dialyser and blood lines Int J Artif Organs 11 4 1988 255 258
127. P.W. Sanders, H. Taylor, J.J. Curtis Hemodialysis without anticoagulation Am J Kidney Dis 5 1 1985 32 35